Progressive-Supranuclear-Palsy-Information-Page

Progressive Supranuclear Palsy Information Page


What research is being done?

PSP is one of the diseases being studied as part of the NINDS Parkinsons Disease Biomarkers Program, which aims to discover ways to identify individuals at risk for developing Parkinson's and related disorders, and to track disease progression.  Other researchers are studying genes that might increase a person's risk of developing PSP and to identify specific disease-causing mutations, which could point to additional targets for therapy development.  Investigators ae also developing animal models of PSP and other protein tau-related disorders, for research on disease mechanisms and preclinical testing of potential drugs.

Information from the National Library of Medicine’s MedlinePlus
Progressive Supranuclear Palsy

×
What research is being done?

PSP is one of the diseases being studied as part of the NINDS Parkinsons Disease Biomarkers Program, which aims to discover ways to identify individuals at risk for developing Parkinson's and related disorders, and to track disease progression.  Other researchers are studying genes that might increase a person's risk of developing PSP and to identify specific disease-causing mutations, which could point to additional targets for therapy development.  Investigators ae also developing animal models of PSP and other protein tau-related disorders, for research on disease mechanisms and preclinical testing of potential drugs.

Information from the National Library of Medicine’s MedlinePlus
Progressive Supranuclear Palsy

PSP is one of the diseases being studied as part of the NINDS Parkinsons Disease Biomarkers Program, which aims to discover ways to identify individuals at risk for developing Parkinson's and related disorders, and to track disease progression.  Other researchers are studying genes that might increase a person's risk of developing PSP and to identify specific disease-causing mutations, which could point to additional targets for therapy development.  Investigators ae also developing animal models of PSP and other protein tau-related disorders, for research on disease mechanisms and preclinical testing of potential drugs.

Information from the National Library of Medicine’s MedlinePlus
Progressive Supranuclear Palsy


Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications
30 E. Padonia Road
Suite 201
Timonium, MD 21093
Tel: 410-785-7004; 800-457-4777
National Institutes of Health, DHHS
8600 Rockville Pike, Bldg. 38, Rm. 2S10
Bethesda, MD 20894
Tel: 301-496-6308; 888-346-3656